Editing China Reports Progress In Swine Fever Vaccine Trials

A widespread outbreak of swine fever wiped out about 40 percent of China's pig herd<br>  <br>A vaccine developed in China for African swine fever, which devastated the country's pig herd and caused pork prices to soar,  [https://www.kynghidongduong.vn/tours/tour-trung-quoc-huu-nghi-quan-nam-ninh-que-lam-4-ngay.html kynghidongduong.vn] is progressing smoothly, according to results reported on Wednesday.<br> <br>The widespread outbreak of swine fever since August 2018 has disrupted the supply of pork in China, where it is a staple meat, with millions of animals culled.<br> <br>The [http://www.dict.cc/englisch-deutsch/disease.html disease] wiped out about 40 percent of the country's pig herd, causing prices to rocket as officials struggled to stabilise supplies.<br> <br>Authorities have since been looking into means of preventing the disease, and the vaccine strain passed a [http://www.europeana.eu/portal/search.html?query=national%20review national review] in December 2019, according to a report by the China Science Daily posted on the website of the Chinese Academy of Agricultural Sciences (CAAS).<br> <br>In March, the vaccine was approved by the agriculture ministry for clinical trials in northern Heilongjiang province, central Henan province and northwest Xinjiang region.<br> <br>Clinical trials of the vaccine developed by the Harbin Veterinary Research Institute were seeing "smooth progress", according to the CAAS.<br> <br>About 3,000 pigs are involved in the ongoing trials, launched between April and June, with the animals in "good condition", said the report.<br> <br>Vaccinated sows have not shown abnormal clinical conditions or miscarriages, and the pigs have not made any toxic discharge of the vaccine.<br> <br>Since immunisation,  [https://www.kynghidongduong.vn/tours/tour-trung-quoc-huu-nghi-quan-nam-ninh-que-lam-4-ngay.html tour du lịch quế lâm] the fatality rate has been under one percent, and the immunised herd has not shown significant differences to the control group.<br> <br>The CAAS is expected to "accelerate the development of the vaccine" in the next step.<br>